These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4400005)

  • 1. [Side effects of neuroleptics in compound preparations].
    Schulte PW; Zimmermann H
    Med Klin; 1971 Nov; 66(48):1644-8. PubMed ID: 4400005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transitory exacerbations arising during the course of neuroleptic therapy].
    Gurovich IIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of individual tolerance, behavior and phenothiazine produced extrapyramidal system disturbance.
    Simpson GM; Kunz-Bartholini E
    Dis Nerv Syst; 1968 Apr; 29(4):269-74. PubMed ID: 5652493
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].
    Korn M; Pinchard A; Breulet M; Goffioul F; Bobon J
    Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of intramuscular thiothixene and trifluoperazine in psychotic patients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol J New Drugs; 1968; 8(6):400-3. PubMed ID: 4883787
    [No Abstract]   [Full Text] [Related]  

  • 6. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O; Heller S
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
    Tetreault L; Filotto J; Bordeleau JM
    Can Psychiatr Assoc J; 1968 Dec; 13(6):507-12. PubMed ID: 5726835
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Nardini M; Fanali A; Sorgonà F; Vergnano M; Fieschi G
    Minerva Med; 1971 Oct; 62(82):4020-3. PubMed ID: 5125070
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patients.
    Ananth JV; Horodesky S; Lehmann HE; Ban TA
    Laval Med; 1970 Sep; 41(7):934-8. PubMed ID: 5509491
    [No Abstract]   [Full Text] [Related]  

  • 10. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A; Nardini M; Sorgona F
    Sist Nerv; 1970; 22(5):273-85. PubMed ID: 5514245
    [No Abstract]   [Full Text] [Related]  

  • 11. [Extrapyramidal complications of psychopharmacological drugs].
    Vacek J
    Cesk Psychiatr; 1969 Dec; 65(6):414-21. PubMed ID: 4983105
    [No Abstract]   [Full Text] [Related]  

  • 12. [Persistent extrapyramidal oral dyskinesia following administration of thymoleptics].
    Sedivec V; Valenová Z; Paceltová L
    Cesk Psychiatr; 1969 Aug; 65(4):241-4. PubMed ID: 5807247
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C; Merlis S
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extrapyramidal accidents in outpatient therapy].
    Rouleau Y
    Laval Med; 1970 Sep; 41(7):906-8. PubMed ID: 5509488
    [No Abstract]   [Full Text] [Related]  

  • 15. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital.
    Guttman H; Lehmann HE; Ban TA
    Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661
    [No Abstract]   [Full Text] [Related]  

  • 16. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.
    Lehmann HE; Ban TA; Saxena BM
    Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489
    [No Abstract]   [Full Text] [Related]  

  • 17. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Lange J
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract]   [Full Text] [Related]  

  • 18. [An original psychotropic drug: sulpiride].
    Borenstein P; Champion C; Cujo P; Gekière F; Olivenstein C; Kramarz P
    Sem Hop; 1969 Apr; 45(19):1301-14. PubMed ID: 4307000
    [No Abstract]   [Full Text] [Related]  

  • 19. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa; Fleĭs EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract]   [Full Text] [Related]  

  • 20. Troxonium tosylate in the treatment of drug-induced extrapyramidal manifestations.
    Koh CV; Ananth JV; Ban TA; Lehmann HE
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):289-91. PubMed ID: 4931413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.